Summary & Overview
HCPCS L8684: External Radiofrequency Transmitter for Sacral Neurostimulator Replacement
HCPCS Level II code L8684 designates an external radiofrequency transmitter used with an implantable sacral root neurostimulator receiver for bowel and bladder management, specifically for replacement of the external transmitter. This code matters nationally as sacral neuromodulation is an established therapy for refractory urinary and fecal dysfunction, and accurate device coding supports appropriate supply tracking, billing, and device lifecycle management across payers.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an explanation of what L8684 represents clinically and operationally, typical places of service, and which payers commonly adjudicate claims for external neurostimulation transmitters. The publication also highlights benchmarks and billing considerations tied to device replacement claims, summarizes relevant policy themes affecting coverage of implantable neuromodulation system components, and provides clinical context on the role of external transmitters in sacral neuromodulation therapy.
This executive summary equips billing staff, DME suppliers, and health policy stakeholders with concise guidance on the code’s purpose, payer landscape, and areas to examine when preparing and auditing claims for external sacral neurostimulator transmitters.
Billing Code Overview
HCPCS Level II code L8684 describes a radiofrequency transmitter (external) for use with an implantable sacral root neurostimulator receiver for bowel and bladder management, replacement. The device is an external component that transmits radiofrequency signals to an implanted sacral root neurostimulator receiver to support neuromodulation therapy for bowel and bladder control.
-
Service type: Durable medical device replacement service for neuromodulation system components
-
Typical site of service: Outpatient durable medical equipment provision, ambulatory surgical centers, or other outpatient clinics where device replacement and follow-up for implantable neurostimulation systems occur
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with medically refractory neurogenic bladder and/or bowel dysfunction due to spinal cord injury, multiple sclerosis, or other sacral nerve-related pathology who previously received an implantable sacral root neurostimulator receiver. The implanted system communicates with an external L8684 radiofrequency transmitter (external) that powers and programs the implanted receiver for bowel and bladder management. A realistic scenario: a patient presents to an outpatient specialty clinic or ambulatory surgery center for replacement of a malfunctioning or lost external transmitter. Clinic staff confirm device model and implant compatibility, verify patient identity and consent, interrogate the implanted receiver with the new external transmitter, program stimulation parameters, perform a functional test (voiding/bowel response), document device serial numbers, and provide patient education on use and troubleshooting. Typical site of service is an outpatient neuromodulation clinic, ambulatory surgery center, or hospital outpatient department. The multidisciplinary workflow often involves a urologist or colorectal surgeon, or an implanting pain/neurostimulation physician, supported by device representatives and trained clinical staff.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Office or other outpatient visit for the evaluation and management of an established patient | Use when replacement and device interrogation occur during a scheduled outpatient visit with billed E/M services. |